Hypogonadism Completed Phase 2 Trials for Testosterone (DB00624)

IndicationStatusPhase
DBCOND0009256 (Hypogonadism)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00857961A Study of the Pharmacokinetics of Testosterone Metered Dose (MD)-Lotion FormulationsTreatment